review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1093/EURHEARTJ/EHV322 |
P698 | PubMed publication ID | 26152116 |
P50 | author | Michele De Bonis | Q37828995 |
Piotr Suwalski | Q85551345 | ||
Bernard Iung | Q86271327 | ||
Bernard D Prendergast | Q89700440 | ||
Raphael Rosenhek | Q114244154 | ||
Claudio Muneretto | Q117265578 | ||
Volkmar Falk | Q43778131 | ||
Michael A. Borger | Q56475856 | ||
Patrizio Lancellotti | Q61863551 | ||
Prakash Punjabi | Q63360731 | ||
Francesco Maisano | Q80794087 | ||
P2093 | author name string | Nawwar Al-Attar | |
Alec Vahanian | |||
Olaf Wendler | |||
Salvatore Lentini | |||
Luc Pierard | |||
David Messika-Zeitoun | |||
Thierry Folliguet | |||
Filip Casselman | |||
Phillipe Pibarot | |||
Manuel Antunes | |||
P2860 | cites work | Mitral-valve repair versus replacement for severe ischemic mitral regurgitation | Q30411350 |
Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. | Q30457109 | ||
Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study | Q30458586 | ||
Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study | Q34244939 | ||
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium | Q34492675 | ||
ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease | Q35937749 | ||
Chronic ischemic mitral regurgitation: repair, replace or rethink? | Q36401217 | ||
??? | Q28267062 | ||
Percutaneous transcatheter mitral valve repair: a classification of the technology | Q37830846 | ||
Overview of the 2013 Food and Drug Administration Circulatory System Devices Panel meeting on the MitraClip Delivery System | Q38130207 | ||
Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy | Q38444976 | ||
Percutaneous repair or surgery for mitral regurgitation | Q38475417 | ||
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines | Q39602779 | ||
Guidelines on the management of valvular heart disease (version 2012). | Q40276570 | ||
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation | Q43612383 | ||
Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). | Q43629648 | ||
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation | Q43743936 | ||
Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. | Q43813825 | ||
Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience | Q43925810 | ||
The lottery of mitral valve repair surgery | Q44217891 | ||
Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome | Q44263280 | ||
MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry | Q44535425 | ||
Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries | Q44687910 | ||
Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach | Q44711151 | ||
Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial | Q44754565 | ||
Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery | Q44769116 | ||
Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. | Q45244379 | ||
Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. | Q45332647 | ||
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. | Q46171054 | ||
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). | Q46311428 | ||
A 20-year experience with mitral valve repair with artificial chordae in 608 patients | Q47647578 | ||
Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation | Q47782852 | ||
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease | Q47797002 | ||
Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation | Q48089126 | ||
Surgical revision after percutaneous mitral valve repair by edge-to-edge device: when the strategy fails in the highest risk surgical population | Q48119784 | ||
Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target? | Q48499974 | ||
Initial results of the chordal-cutting operation for ischemic mitral regurgitation. | Q48594330 | ||
Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip | Q48751619 | ||
The papillary muscle sling for ischemic mitral regurgitation. | Q51726137 | ||
Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: preclinical experience | Q57629574 | ||
Guidelines for reporting mortality and morbidity after cardiac valve interventions | Q57916701 | ||
Long-Term Results (<=18 Years) of the Edge-to-Edge Mitral Valve Repair Without Annuloplasty in Degenerative Mitral Regurgitation: Implications for the Percutaneous Approach | Q57916951 | ||
Similar long-term results of mitral valve repair for anterior compared with posterior leaflet prolapse | Q57917202 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiac surgery | Q235007 |
P304 | page(s) | 133-139 | |
P577 | publication date | 2015-07-07 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease | |
P478 | volume | 37 |
Q34677347 | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib |
Q50196541 | 2017 ESC/EACTS Guidelines for the management of valvular heart disease |
Q39233254 | Cardiac surgery 2016 reviewed |
Q47675107 | Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study |
Q36050341 | Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies |
Q56964413 | Extraction of open-state mitral valve geometry from CT volumes |
Q38635629 | Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review. |
Q58804694 | Imaging of Valvular Heart Disease in Heart Failure |
Q64890781 | Indirect Annuloplasty to Treat Functional Mitral Regurgitation: Current Results and Future Perspectives. |
Q37240400 | Is Mitral Valve Repair Superior to Mitral Valve Replacement in Elderly Patients? Comparison of Short- and Long-Term Outcomes in a Propensity-Matched Cohort |
Q90529157 | Isolated Mitral Valve Repair in Patients with Reduced Left Ventricular Ejection Fraction |
Q59390669 | Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review |
Q40675045 | Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach |
Q38667322 | Mitral regurgitation. Timing of surgery or interventional treatment |
Q26747060 | Mitral valve repair |
Q39456015 | Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation |
Q36050357 | Neuroprotective effects of female sex steroids in humans: current controversies and future directions |
Q99583774 | Past, current and future management of secondary mitral valve disease: the importance of anatomic staging |
Q26781785 | Percutaneous and minimally invasive approaches to mitral valve repair for severe mitral regurgitation-new devices and emerging outcomes |
Q93055522 | Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years |
Q64270165 | Pilot study of totally thoracoscopic periareolar approach for minimally invasive mitral valve surgery. Towards even less invasive? |
Q47567410 | Refining the prognostic impact of functional mitral regurgitation in chronic heart failure |
Q40847130 | The year in cardiology 2015: valvular heart disease |
Q47864364 | Three-dimensional transoesophageal echocardiography is crucial for valid assessment of mitral valve leaflet morphology in severe mitral regurgitation prior to interventional repair. |
Q86894543 | [Surgical techniques in mitral valve diseases. Reconstruction and/or replacement] |
Search more.